OBJECTIVE Patients with diabetes may experience high burden of treatment (BOT), including treatment-related effects and self-care demands. We examined whether patients with type 2 diabetes and their clinicians discuss BOT, the characteristics of their discussions, and their attempts to address BOT during visits. RESEARCH DESIGN AND METHODS Two coders independently reviewed videos of 46 primar...

Boresch, K., Zts. Bot., 13, 65-78 (1921). Emerson, R., and Arnold, W., Jour. Gen. Physiol., 16, 191-205 (1932). Engelmann, Th. W., Bot. Ztg., 41, 1-13 (1883). Gaidukov, N., Anhang Abhandl. preuss. Akad. Wiss., 1-36 (1902). Harder, R., Ber. deutsch. bot. Ges., 40, 26-32 (1922). Harder, R., Zts. Bot., 15, 305-355 (1923). Oltmanns, Fr., Jahrb. wiss. Bot., 23, 349-440 (1893). v. Richter, A., Ber. d...

Bot-like malware has posed an immense threat to computer security. Bot detection is still a challenging task since bot developers are continuously adopting advanced techniques to make bots more stealthy. A typical bot exhibits three invariant features along its onset: (1) the startup of a bot is automatic without requiring any user actions; (2) a bot must establish a command and control channel...

BACKGROUND Borderline tumors of the ovary (BOT) are a distinct entity of ovarian tumors, characterized by lack of stromal invasion. Recent studies postulated that the presence of invasive implants, incomplete staging, fertility sparing surgery and residual tumor after surgery are major prognostic factors for BOT. There are no biomarkers that can predict BOT or the presence of invasive implants....

BACKGROUND The lack of consensus around best practices for management of borderline ovarian tumors (BOT) is, in part, to the lack of available data and of clarity in interpreting relationships among various factors that impact outcomes. The objective of this study was to identify clinicopathological factors that impact prognosis of patients with borderline ovarian tumors (BOT) and to address fe...